# Exploration of the Fusidic Acid Structure Activity Space for Antibiotic Activity

**Authors:** Yoon-Suk Kang, Simone C. Silva, Kenneth Smith, Krissty Sumida, Yuhan Wang, Lucius Chiaraviglio, Ramachandra Reddy Donthiri, Alhanouf Z. Aljahdali, James E. Kirby, George A. O’Doherty

PMC · DOI: 10.3390/molecules30030465 · Molecules · 2025-01-21

## TL;DR

This study explores how modifying the structure of fusidic acid can improve its antibiotic activity, particularly against Gram-positive bacteria.

## Contribution

The study identifies specific structural modifications to fusidic acid that retain or enhance its antibacterial activity.

## Key findings

- Modifications to the A-ring alcohol of fusidic acid retained modest activity against Gram-positive bacteria.
- Side-chain carboxylic acid esters and C-ring oxidations were ineffective or poorly tolerated.
- The fusidic acid pyrazine-2-carboxylate may act as a pro-drug based on activity differences in assays.

## Abstract

Fusidic acid is a translation inhibitor with activity against major Gram-positive bacterial pathogens such as S. aureus. However, its activity against Gram-negatives is poor based on an inability to access its cytoplasmic target in these organisms. Opportunities for functionalization of the fusidic acid scaffold to enhance activity against Gram-negative pathogens have not been explored. Using an activity-guided synthetic strategy, the tolerance of the tetracyclic natural product to derivatization at the A- and C-rings and its carboxylic acid side chain was explored with the goal of enhancing its activity spectrum and pharmacological properties. All side-chain carboxylic acid esters were inactive. Oxidation of the C-ring alcohol and oxime were not tolerated either. A number of esters of the A-ring alcohol retained modest activity against Gram-positive bacteria and were informative for future activity-guided studies. For the A-ring esters, differences in antibacterial activity relative to inhibitory activity in a ribosome in vitro translation assay suggested the possibility of a pro-druglike effect for the fusidic acid pyrazine-2-carboxylate. This study furthers the understanding of the activity of the fusidic acid scaffold against Gram-positive bacteria. These results suggest promise for future modification of the A-ring alcohol of fusidic acid in the advancement of its antibiotic properties.

## Linked entities

- **Chemicals:** fusidic acid (PubChem CID 3000226), pyrazine-2-carboxylate (PubChem CID 3728869)

## Full-text entities

- **Diseases:** bacterial (MESH:D001424)
- **Chemicals:** esters (MESH:D004952), carboxylic acid esters (-), alcohol (MESH:D000438), carboxylic acid (MESH:D002264), oxime (MESH:D010091), Fusidic Acid (MESH:D005672), pyrazine-2-carboxylate (MESH:C553563)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11820832/full.md

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11820832/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC11820832/full.md

---
Source: https://tomesphere.com/paper/PMC11820832